Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 85/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06885931Not ApplicableRecruiting

Augmenting Urinary Reflex Activity Study 4 (Including eXtended Indications)

Role: lead

NCT06597994Not ApplicableActive Not Recruiting

Augmenting Urinary Reflex Activity: Study 3

Role: lead

NCT05241379Not ApplicableCompleted

AURA-2: Augmenting Urinary Reflex Activity

Role: lead

NCT05256498Not ApplicableWithdrawn

AURA 1: Augmenting Urinary Reflex Activity: Study 1

Role: lead

All 4 trials loaded